“Extending the Cure,” a research project of the Center for Disease Dynamics, Economics & Policy that looks at antibiotic resistance, on Wednesday launched a map “designed to be a tool for public health, researchers, doctors, the media and the public to track resistant pathogens, which is a growing problem around the world,” the Washington Post’s “The Checkup” blog reports. The “ResistanceMap,” funded in part by the Robert Wood Johnson Foundation, “compiles data from a variety of sources,” including the CDC, FDA, European Antimicrobial Resistance Surveillance Network and Canadian Antimicrobial Resistance Alliance, the blog notes. “Among the trends the map illustrates is that Western Europe is doing a better job than the United States of controlling certain resistant microbes, … [t]he United States and Ireland have the highest rates of vancomycin-resistant enterococcus (VRE),” and “[t]he South has higher rates of resistance compared to the West or Northeast in the United States,” the blog writes (Stein, 9/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.